Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Gynecologic 1Breast 1

Conditions

Endometrial Neoplasms 3Ovarian Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma 1Pregnancy Complications 1Overweight 1Obesity 1Leiomyoma 1Inflammation 1Infertility, Female 1Infertility 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Tirzepatide 3Methods 3Surveys and Questionnaires 2Resistance Training 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2semaglutide 1atezolizumab 1Yoga 1Therapeutics 1Tablets 1TIC10 compound 1Sampling Studies 1Psychology, Positive 1Patient Navigation 1Neuroimaging 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1Early Intervention, Educational 1Diet, Mediterranean 1Diet Therapy 1Counseling 1Body Weight Maintenance 1Blood Specimen Collection 1Blood Glucose Self-Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Tablets × Gynecologic × Clear all
NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Recruiting
89 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡